Inhalation Sciences AB (publ) releases Q2 Report 2024
(Stockholm, Sweden, 28 August 2024) Inhalation Sciences AB announces that its Q2 Report for 2024 is now available on the company’s website.To read the whole report (in Swedish), visit: http://inhalation.se/investors/finansiella-rapporter/ CEO statement Our journey towards achieving the company's strategic goals has continued during the second quarter. We have worked purposefully towards a positive cash flow, which has yielded results in the form of an improved operating profit of 24% by the first half of 2024, compared to the same period the year before. Our pipeline in the form of